The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Combined genomic profiling of cell-free DNA (cfDNA) and circulating tumor cell DNA (ctcDNA) in S1802, a prospective phase 3 trial for metastatic prostate cancer (mHSPC).
 
Daniel Bsteh
No Relationships to Disclose
 
Jonathan Buckley
No Relationships to Disclose
 
Scott Mitchell
No Relationships to Disclose
 
Dejerianne Ostrow
No Relationships to Disclose
 
Jean-Hugues Parmentier
No Relationships to Disclose
 
Samin Jahan
No Relationships to Disclose
 
Seth Sadis
Employment - Thermo Fisher Scientific
Stock and Other Ownership Interests - Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - I hold patents related to my work at Thermo Fisher Scientific.
Travel, Accommodations, Expenses - Thermo Fisher Scientific
 
Jeff Smith
Employment - Thermo Fisher Scientific
Leadership - Thermo Fisher Scientific
Stock and Other Ownership Interests - Thermo Fisher Scientific
 
Jingwei NI
No Relationships to Disclose
 
Xinzhan Peng
Employment - Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - patent application: "LIBRARY PREPARATION METHODS AND COMPOSITIONS AND USES THEREFOR" (Inst); Patent application: "POLYMERASE COMPOSITIONS & METHODS" (Inst); Patent: "Library preparation methods and compositions and uses therefor" (Inst); Patent: "Polymerase compositions and methods" (Inst)
 
David McConkey
Honoraria - H3 Biomedicine; Janssen Oncology
Consulting or Advisory Role - CG Oncology; Owkin
Research Funding - Convergent Genomics
 
Tanya Dorff
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; Novartis; Pfizer
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Hookipa Biotech (Inst); Janssen Oncology (Inst); Promontory Therapeutics (Inst)
 
Seth Lerner
Stock and Other Ownership Interests - Aura Biosciences; C2i genomics
Honoraria - Grand Rounds in Urology; UroToday
Consulting or Advisory Role - AstraZeneca; Aura Biosciences; Bristol-Myers Squibb Foundation/Janssen; C2i Genomics; Ferring; Gilead Sciences; ImmunityBio; Incyte; Pfizer/EMD Serono; Protara Therapeutics; Stimit; Urogen pharma; Vaxiion; Verity Pharmaceuticals
Research Funding - Aura Biosciences; Endo Pharmaceuticals; FKD Therapies; Japan BCG Laboratory; QED Therapeutics; Roche/Genentech; SURGE Therapeutics; Vaxiion; Viventia Biotech
Patents, Royalties, Other Intellectual Property - TCGA expression subtype singel patient classifier
Other Relationship - Bladder Cancer Journal; UpToDate
 
Ana Aparicio
Honoraria - Advanced Accelerator Applications/Novartis; Astellas Pharma; Bayer; Bristol-Myers Squibb Pharmaceuticals; Daiichi Sankyo; Genzyme; GlaxoSmithKline; Janssen; Pfizer
Consulting or Advisory Role - Advanced Accelerator Applications/Novartis; American Cancer Society; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Daiichi Sankyo Inc.; Genzyme; GlaxoSmithKline; Janssen Research & Development; Pfizer
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Daiichi Sankyo (Inst); Janssen (Inst); Polaris (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; GlaxoSmithKline
 
Brian Chapin
Consulting or Advisory Role - Blue Earth Diagnostics; Johnson and Johnson
Research Funding - Blue Earth Diagnostics; Regeneron (Inst)
(OPTIONAL) Uncompensated Relationships - Janssen; Merck; Pfizer; Regeneron
 
Vinay Duddalwar
No Relationships to Disclose
 
Timothy Triche
Patents, Royalties, Other Intellectual Property - I have created and patented through Children's Hospital Los Angeles targeted nanoparticle small molecule (e.g., irinotecan, doxorubicin) delivery technology for the treatment of cancer. I also have a provisional patent filed for similar nanoparticle techn; The second provisional patent was granted. It has no impact on financial disclosures and has not generated any revenue. (Inst)
 
Amir Goldkorn
Research Funding - Menarini Silicon Biosystems; RareCyte; Thermo Fisher Scientific
Patents, Royalties, Other Intellectual Property - I am listed as a co-inventor on a patent held jointly by USC and Caltech for a microfilter we developed for capturing live circulating tumor cells from blood.